CRVS — Corvus Pharmaceuticals, Inc. stock price, charts and financials

QT86Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
13.74
-0.18-1.29%
OverviewShort InterestFilings
CRVSQT86Corvus Pharmaceuticals, Inc.·NASDAQ
13.74-1.29%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 22, 20268-KCurrent report
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
May 20, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 14, 20268-KCurrent report
May 07, 2026S-8Registration of employee benefit securities
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
Apr 27, 20263Initial statement of beneficial ownership
Apr 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 27, 20264Statement of changes in beneficial ownership
Apr 24, 2026DEF 14ADefinitive proxy statement
Apr 24, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 20268-KCurrent report
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 236
Page
▼
/ 10